PRINCIPAL DISPLAY PANEL
(calcipotriene 0.005% and betamethasone dipropionate 0.064%) Topical Suspension
For Topical Use Only
Net Wt. 60 g
Each gram contains 52.18 mcg of calcipotriene hydrate (equivalent to 50 mcg of calcipotriene) and 0.643 mg of betamethasone dipropionate (equivalent to 0.5 mg of betamethasone) in a base of hydrogenated castor oil, PPG-15 stearyl ether and mineral oil.
Store Taclonex Scalp® Topical Suspension between 20-25°C (68-77°F). Excursions permitted between 15-30°C (59-86°F). Do not refrigerate. Keep the bottle in the outer carton when not in use. Shake before use.
Discard product three months after opening.
Keep out of the reach of children.
Usual dosage: Apply once daily, or as directed by physician. See insert for complete information.
| TACLONEX SCALP |
calcipotriene and betamethasone dipropionate suspension
|Labeler — Physicians Total Care, Inc. (194123980)|
|Physicians Total Care, Inc.||194123980||relabel|
Revised: 08/2010 Physicians Total Care, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.